Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas Harboring a PI3KCA Mutation/Amplification and/or a PTEN Loss
Clinical trial NCT02822482 · TERMINATED
Trial details
- NCT number
- NCT02822482
- Sponsor
- UNICANCER
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2019-10-09
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.